PHGE Stock Analysis: Buy, Sell, or Hold?
PHGE - BiomX Inc.
$0.63
0.01 (1.28%)
▲
5d:
-20.59%
30d:
-79.03%
90d:
-84.05%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 21, 2026
11d
Get Alerted When PHGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PHGE is down 20.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PHGE is down 20.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PHGE is currently trading at $0.63, which is considered oversold relative to its 30-day fair value range of $0.76 to $2.82.
Technical Outlook: Technically, PHGE is showing sideways momentum. Immediate support is located at $0.59, while resistance sits at $1.11.
Market Sentiment: PHGE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $304.00 (+48384.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHGE is showing sideways momentum. Immediate support is located at $0.59, while resistance sits at $1.11.
Market Sentiment: PHGE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $304.00 (+48384.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.76 -
$2.82
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48384.8% below Wall St target ($304.00)
- WARNING: Recommendation downgraded due to -20.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.76 -
$2.82
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$1.11
Current Trend
Sideways
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.05
Wall Street Target
$304.00
(+48384.8%)
Share & Embed Analysis
Last updated: May 09, 2026 3:05 PM ET
Data refreshes hourly during market hours. Next update: 4:05 PM
Data refreshes hourly during market hours. Next update: 4:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Reuven Yeganeh
SELL
530000 shares
2026-03-17
Reuven Yeganeh
SELL
450000 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$230 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
